Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler

PatentProstate Cancer

21.10.2024

Prostat Adenokarsinomu Tedavisi İçin Kullanima Uygun Yeni Etken Bileşikler from TRUSTLIFE

ÖZET

Buluş, prostat adenokarsinom hastalığının tedavisinde etkinlik gösterdiği kanıtlananyeni bileşikler ile ilgilidir.

You may also be interested in

  • Our scientific leader Prof. Dr. Adil Mardinoğlu has received the 100th Year Anniversary TÜBİTAK Special Science Award in recognition of his work and achievements in the fields of cell biology and molecular biology.
    Recent News

    Our scientific leader Prof. Dr. Adil Mardinoğlu has received the 100th Year Anniversary TÜBİTAK Special Science Award in recognition of his work and achievements in the fields of cell biology and molecular biology.

  • Next-Generation Drug Safety: Cellular Responses, Toxicological Assessment, and Future Standards
    Blog

    Next-Generation Drug Safety: Cellular Responses, Toxicological Assessment, and Future Standards

  • Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose induced metabolic dysfunction in rats
    Scientific Documents

    Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose induced metabolic dysfunction in rats

Trustlife
About Trustlife Labs Drug R&D Center Contact